Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Hours of Sleep and Myocardial Infarction Risk

This is one of the first studies to prospectively assess this association, and its outcomes support the idea that poor sleep is a potential MI risk factor. 

Cantidad de horas de sueño y riesgo de infarto de miocardio

Even though we need further data to be able to modify the current sleep duration standards as part of life-style change recommendations, it seems reasonable to start bearing this in mind.

Prior observational studies have associated extremes of sleep duration (both little and too much sleep) with MI risk, but confounders have made it hard to reach a definite conclusion. 

This study assessed 461347 participants free of heart disease, classified into three groups according to reported average sleep duration (short sleep <6 hours, between 6 and 9 hours and long sleep >9 hours). Multiple confounders were assessed, even a genetic disposition for heart disease. 


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


Compared against individuals sleeping between 6 and 9 hours, those reporting short sleep had 20% higher MI risk after adjusting for multiple variables (HR: 1.20; CI 95%: 1.07 to 1.33) and those reporting long sleep had 34% higher risk of MI (HR: 1.34; CI 95%: 1.13 to 1.58).

Conclusion

This prospective study looking at sleep duration and MI risk showed a significant association between the two in people sleeping both short and long hours. More data are needed for us to be able to make recommendations to patients as part of a prevention strategy.

Original title: Sleep Duration and Myocardial Infarction.

Reference: Iyas Daghlas et al. J Am Coll Cardiol 2019;74:1304–14.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...